| Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers | Kendal YALÇIN,Halil DEĞERTEKİN,M. Nail ALP,Selahattin TEKEŞ,Ömer SATICI,Turgay BUDAK | 157–163 |
| Experience with liver dialysis in acetaminophen induced fulminant hepatic failure: A preliminary report | Meral AKDOĞAN,Karim El-SAHWI,Urooj AHMED,Samy RASHWAN,Anthony SEBASTIAN,Harlan WRIGHT,Bakr NOUR,Ahmet GÜRAKAR | 164–167 |
| Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer | Zeygam SÜLEYMANOV | 168–172 |
| HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases | Necati YENİCE,Fatih GÜLLÜK,Nurten ARICAN,Sembol TÜRKMEN | 173–176 |
| The use of tissue polypeptide specific antigen as a marker in liver diseases | Türkan ÇETİN,ARZU OĞUZ,Pelin ALGAN,İ. Safa YILDIRIM | 177–180 |
| Are serum and biliary carcinoembryonic antigen and carbohydrate antigen 19-9 determinations reliable for differentiation between benign and malignant biliary disease? | Meral AKDOĞAN,Erkan PARLAK,Burçak KAYHAN,Mevhibe BALK,Gül ERSAVAŞTI,Burhan ŞAHİN | 181–184 |
| Tissue transglutaminase expression in duodenal mucosa of patients with celiac disease and of normal subjects | İLYAS TUNCER,İRFAN BAYRAM,İsmet KABA,RIDVAN MERCAN,Serdar UĞRAŞ | 185–188 |
| Emergency bowel surgery in the elderly | Bahadır KÜLAH,Barış GÜLGEZ,M. Mahir ÖZMEN,M. Vasfi ÖZER,FARUK COŞKUN | 189–193 |
| Type 1 gastric carcinoid tumor: Another extrahepatic manifestation of hepatitis C virus infection? | Eser VARDARELİ,Tülay SARIÇAM,Serap IŞIKSOY,Hasan YAVUZ,Ayşegül ÖZAKYOL,Baybora KIRCALI | 194–196 |
| Is celiac sprue an etiology of amyloidosis? | Burçak KAYHAN,Ö. Sedef KURAN,Nesrin TURHAN,Meral AKDOĞAN,Tülin ŞAHİN | 197–199 |
| Atypical presentation of chronic pancreatic fistula: A case successfully managed with long-acting somatostatin | Mahmut C. YAĞMURDUR,Gürden GÜR,Cüneyt AYTEKİN,Hamdi KARAKAYALI,Sedat BOYACIOĞLU,Nevzat BİLGİN |